Obstructive Sleep Apnea: Clinical Trials

3 trials for Obstructive Sleep Apnea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 3
Phase 21Terminated 1

Follow Obstructive Sleep Apnea: new trials by email Literature Review of Obstructive Sleep Apnea trials Research Report on Obstructive Sleep Apnea

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sleep Apnea and Fetal Growth Restriction
S9 VPAP Adapt - Obstructive Sleep Apnea, Fetal Growth Restriction
Phase 3TerminatedWashington University School of Medicine32019-11-182022-03-09
Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea
Ketamine, Control - Sleep Apnea, Obstructive Sleep Apnea
Phase 2 / Phase 3TerminatedUniversity of Alabama at Birmingham92016-06-022019-12-19
Apnex Clinical Study of the Hypoglossal Nerve Stimulation (HGNS®) System to Treat Obstructive Sleep Apnea
Hypoglossal Nerve Stimulation (HGNS) System (Apnex Medical ) - Obstructive Sleep Apnea
Phase 3TerminatedApnex Medical, Inc.1322011-08-012015-04-15

Narrower conditions

Sleep Apnea, Obstructive (3)  ·  Sleep Apnea Syndromes (2)  ·  Apnea (1)  ·  Fetal Growth Retardation (1)  ·  Postoperative Complications (1)  ·  Sleep Wake Disorders (1)

Broader conditions

Dyssomnias (3)  ·  Nervous System Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Respiration Disorders (3)  ·  Respiratory Tract Diseases (3)  ·  Sleep Disorders, Intrinsic (3)  ·  Apnea (2)  ·  Pathologic Processes (2)  ·  Sleep Wake Disorders (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Fetal Diseases (1)  ·  Growth Disorders (1)  ·  Mental Disorders (1)  ·  Neurologic Manifestations (1)

Interventions

Drug Delivery Systems (1)  ·  Ketamine (1)

Sponsors

Apnex Medical, Inc. (1)  ·  University of Alabama at Birmingham (1)  ·  Washington University School of Medicine (1)

Countries

United States (3)  ·  Australia (1)  ·  Israel (1)

Top investigators

Alexander Hincker, MD (1)  ·  Peter A Nagi, MD (1)

Results publications

PMID 34187829